Online Only Articles

Comment on “Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors”

Dong-A University Medical Center, Busan, South Korea
Seoul St. Mary’s Hospital, Cancer Research Institute, The Catholic University of Korea, Seoul, South Korea
Vol. 100 No. 3 (2015): March, 2015